Lundbeck's potential treatment amlenetug for Multiple System Atrophy receives Fast Track Designation from the FDA ...Middle East

The FDA has granted Fast Track Designation to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). Lundbeck has recently initiated MASCOT, a phase III trial to assess efficacy and safety of amlenetug for the treatment of MSA....

Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck's potential treatment amlenetug for Multiple System Atrophy receives Fast Track Designation from the FDA )

Also on site :

• 'He knows where to find me,' Newsom responds to Trump administration arrest threat
• Two people killed by falling trees and thousands without power after storms sweep southern states
• Brynn Whitfield Announces Exit From 'RHONY' After Two Seasons